SEI Investments’s Black Diamond Therapeutics BDTX Stock Holding History

SEI Investments’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$73.4K	Hold	39,683	–	–	﹤0.01%	3213
2026 Q1	$84.5K	Buy	+39,683	New	+$94.4K	﹤0.01%	3121
2025 Q2	–	Sell	-22,802	Closed	-$35.3K	–	2799
2025 Q1	$35.3K	Hold	22,802	–	–	﹤0.01%	2703
2024 Q4	$48.8K	Buy	+22,802	New	+$65.3K	﹤0.01%	2668
2021 Q2	–	Sell	-12,307	Closed	-$299K	–	2547
2021 Q1	$299K	Sell	12,307 -260	-2%	-$7.01K	﹤0.01%	2253
2020 Q4	$403K	Buy	12,567 +1,636	+15%	+$53.7K	﹤0.01%	2084
2020 Q3	$330K	Buy	+10,931	New	+$333K	﹤0.01%	2063

Other funds holding BDTX

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

SEI Investments's BDTX Position: Q2 2026 in Review

SEI Investments held its Black Diamond Therapeutics (BDTX) position steady in Q2 2026 at 39,683 shares worth $73.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3213.

SEI Investments first reported a position in BDTX in Q3 2020 and has held it in 7 quarters since. The position peaked at $403K in Q4 2020. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

SEI Investments held 39,683 shares of Black Diamond Therapeutics worth $73.4K as of Q2 2026.
SEI Investments left its Black Diamond Therapeutics share count unchanged in Q2 2026.
Black Diamond Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #3213 holding.
SEI Investments first reported a position in Black Diamond Therapeutics in Q3 2020 and has held it in 7 quarters since.
SEI Investments's Black Diamond Therapeutics position peaked at $403K in Q4 2020.
96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.